CASE STUDY

AAV Delivery in Hepatic Stellate Cells

Measure transduction efficiency in primary, human, hepatic stellate cells (HSCs).

OVERVIEW

Review a custom project designed to measure AAV transduction efficiency and effect on viability in hepatic stellate cells (HSCs).

Representative images of HSCs after treatment with AAV2.

Browse representative images and data comparing the transduction of AAV2 and AAV9 in primary, human, hepatic stellate cells.

CASE STUDY

Review an example of a study designed to measure transduction efficiencies of AAV gene-therapy candidates in a model of Parkinson's disease.

BLOG POST

Learn more about the significance of AAVs as gene-therapy vectors and practical considerations for their use.

BROCHURE

Learn about how PhenoVista's R2G AAV Gene Delivery Assay Service can help you assess AAV transduction in various cell types.

Let's discuss how we can help with your next study.

DOWNLOAD THE CASE STUDY

Overview

Review an example of a study designed to measure fibrosis induction and inhibition in hepatic stellate cells (HSCs).

Highlights